NCT05730816View on ClinicalTrials.gov

MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI

PHASE2RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

April 3, 2027

Study Completion Date

January 1, 2028

Conditions
Mesothelioma
Interventions
DRUG

Magnesium sulfate

Intravenous infusion of magnesium sulfate prior to intraoperative chemotherapy with cisplatin.

DRUG

Normal Saline

Intravenous infusion of normal saline.

Trial Locations (1)

02130

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Brigham and Women's Hospital

OTHER